These results suggest that fasting closer to 13 h may be necessary to sufficiently clear gastric solids in patients on GLP-1 therapy
It also helps reduce hunger, so people feel full quicker and stay full longer, which helps them eat less
Reduced Risk of Cardiovascular Events: Some GLP-1 medications have shown promise in reducing the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes and existing heart disease
Therefore, decreasing ROS accumulation is indispensible to survive under stress, which is accomplished by inducing enzymatic and nonenzymatic antioxidant defense pathways
more information on these can be found at For many of the physical harms listed here, it is common for users to attempt to mitigate these effects by using ancillary drugs
1169 (60%) had cerebral infarction, 296 (15%) haemorrhagic stroke, 106 (5%) TIA and 379 (20%) stroke mimics